The manufacturers of generic valsartan medications have been under intense scrutiny since it was discovered that certain formulations of the drug contained harmful, cancer-causing impurities. This article delves into the […]
Valsartan Bellwether Lawsuit Over Cancer Claims Scheduled for 2025 Read More »
Lawsuits over the alleged link between valsartan and cancer have raised serious concerns about the safety of this widely prescribed blood pressure medication. Reports of contamination with N-nitrosodimethylamine (NDMA), a
Valsartan Lawsuit MDL: Latest Updates on Cancer-Related Claims Read More »
In a notable development in the ongoing valsartan litigation, lawyers are nearing a settlement agreement for those who sued Hetero, a manufacturer of the generic blood pressure medication that was
One of the key players involved in the ongoing valsartan NDMA litigation has agreed to a settlement of valsartan lawsuits, providing some relief to individuals impacted by the contaminated blood
Valsartan Litigation Update: Hetero Settles Personal Injury and Economic Loss Claims Read More »
More than five years after the initial valsartan recalls, the U.S. District Judge overseeing the valsartan litigation has greenlit the first trial against manufacturers and distributors of the tainted generic
First Valsartan NDMA Cancer Lawsuit Cleared to Proceed to Trial Read More »
